Kim Smith-Whitley - 01 Jun 2021 Form 4/A - Amendment Insider Report for Global Blood Therapeutics, Inc.

Role
Officer
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
21 Jun 2021, 16:05:52 UTC
Date Of Original Report
02 Jun 2021
Previous filing
07 May 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Restricted Stock Units Award $0 +42,400 $0.000000 42,400 01 Jun 2021 Common Stock 42,400 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2 The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, subject to the Reporting Person's continuous service with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Remarks:

Title: EVP, Head of Research & Development Due to an administrative error on the original filing, this Form 4/A corrects the number of Restricted Stock Units granted to the Reporting Person on June 1, 2021 from 6,300 units to 42,400 units. EXHIBIT 24: Power of Attorney